Study finds better adherence among patients in medication-synchronization programs
WASHINGTON — Patients who received appointment-based medication synchronization were up to six times more likely to adhere to their therapies than those who didn’t, according to a study of patients at rural Thrifty White Pharmacy locations in the Midwest published in the Journal of the American Pharmacists Association.
The study, which appears in JAPhA‘s November/December issue, found that patients in the appointment-based medication synchronization, or ABMS group, were 3.4-6.1 times more likely to be adherent, while those in the control group were 52% to 73% more likely to stop taking chronic medications over the course of a year. Overall, the patients in the ABMS program showed adherence rates of 66.1% to 75.5% over the year, compared with 37% to 40.8% among control patients. The study took place in rural pharmacies in the Midwest between June 30, 2011 and Oct. 31. 2012.
"This research shows appointment-based medication synchronization to be one of the most effective interventions available to help patients take their medications," lead study author and Virginia Commonwealth University pharmacy professor David Holdford said. "Widespread implementation in pharmacies across the United States can have a major impact on patient health."
New Rite Aid group VP pharmacy initiatives and clinical services to oversee Wellness Ambassador program
CAMP HILL, Pa. – Rite Aid has promoted Karen Staniforth, VP pharmacy for the chain’s mid-Atlantic division, to group VP pharmacy initiatives and clinical services, the company said Monday.
In the new position, Staniforth will oversee Rite Aid’s strategy around the Wellness Ambassadors, specially trained staff who work in its Wellness stores, answering customers’ questions about health and wellness products and directing them to the pharmacy as needed. She will report to SVP pharmacy Dan Miller.
"Throughout her career, Karen has garnered critical knowledge and experience across several functional areas of the chain drug industry, making her a true asset to our company," Miller said. "Her valuable insights will guide us as we work to advance our clinical services and Wellness Ambassador programs, helping us highlight the expertise of our more than 11,000 pharmacists and providing superior care and health outcomes for our patients nationwide."
Staniforth started her pharmacy career in 1982 in Johannesburg and became regional sales manager for Novartis Pharmaceuticals in 1991, overseeing retail sales operations for the Swiss drug maker in Cape Town, South Africa. She began working for Rite Aid in 1998 as a graduate pharmacy intern after moving to the United States.
QS/1 announces signature capture tablet
SPARTANBURG, S.C. – QS/1, a healthcare automation solutions provider, has announced the integration of Dell’s Latitude 10 tablet with its Pharmacy Management Systems. The Latitude 10 can be utilized as a wireless signature capture device for pharmacies with a drive-thru and also provides functionality in other areas.
“The Latitude 10 is more than a tablet,” Charles Garner, QS/1 Market Analyst said. “It is truly a full-functioning computer that you can carry around the pharmacy.”
The Latitude 10 comes with Windows 8 and runs QS/1’s NRx Pharmacy Management System through a client connection. This allows pharamcies to perform such duties as patient counseling in a quiet, isolated area of the store.
“It is ideal in a pharmacy setting because it comes with an optional ruggedized protective case,” Garner added. “It not only helps you collect signatures at the drive-thru, it also helps improve your pharmacy’s workflow by adding new patients, entering refills and working on patient outcomes.”
QS/1 customers interested in adding Dell Latitude 10 can contact QS/1 Upgrades to order.